United States · FDA National Drug Code directory
OPDIVO QVANTIG
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0003-6120_1ce25608-1b8f-4d49-9ffd-6c8c61bf4f1a
- Product NDC
- 0003-6120
- Form
- INJECTION, SOLUTION
- Composition / generic term
- nivolumab and hyaluronidase-nvhy
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250102
- Source listing expiry
- 20271231
Source-listed ingredients
- NIVOLUMAB — 120 mg/mL
- HYALURONIDASE (HUMAN RECOMBINANT) — 2000 U/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-6120-01) / 5 mL in 1 VIAL, SINGLE-DOSE · 0003-6120-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →